Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
about
Emerging Therapeutics in Pulmonary Hypertension.Pulmonary Comorbidity in Lung Cancer.Metabolic reprogramming in the pathogenesis of chronic lung diseases including BPD, COPD, and pulmonary fibrosis.Hypertension: Promising mitochondria-targeting drug for PAH.Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study.Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountainsTargeting PDK4 inhibits breast cancer metabolismUncoupling Protein 2 in Cardiovascular Health and DiseaseAlpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathwayPyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival
P2860
Q47700134-2345C1B6-D115-4409-B9BC-B751BC27C729Q49341886-1BC882B8-7A93-4D73-BC8B-36040EF118A4Q49918024-CEBA6994-EAC9-46CB-9C11-8EA0B9DD5044Q49971234-4C6F7334-806D-4F50-8460-8B1586E6BCFFQ55265238-629467AF-8AA9-4C8A-B22D-992AD5EF3D1CQ55499525-802A7DCF-F8FF-46AC-9B5B-B83B66AA1DC6Q57091761-5BA0F032-2811-4B63-AC3C-9198FFE9F538Q57494133-526EB2C4-AF2F-4028-B0D2-A66A4E5767A0Q58335880-1ECC2FC4-0C0C-433E-A242-E2D4076AFB23Q58705752-344C41BB-81FF-4541-A035-84A0B0CD9293Q58792292-7CB2C757-71E2-4433-A4AE-7B7FC865F968
P2860
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
description
2017 nî lūn-bûn
@nan
2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@en
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@nl
type
label
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@en
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@nl
prefLabel
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@en
Inhibition of pyruvate dehydro ...... etically susceptible patients.
@nl
P2093
P2860
P50
P1476
Inhibition of pyruvate dehydro ...... netically susceptible patients
@en
P2093
Adam Kinnaird
Gareth Barnes
Ian Paterson
J Simon R Gibbs
John Cupitt
Kelvin Chow
Linda Webster
Stephen J Wort
Vikram Gurtu
P2860
P356
10.1126/SCITRANSLMED.AAO4583
P407
P50
P577
2017-10-01T00:00:00Z